TLSI: Trisalus Life Sciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Trisalus Life Sciences Inc (TLSI).
$152.77M Market Cap.
TLSI Market Cap. (MRY)
TLSI Shares Outstanding (MRY)
TLSI Assets (MRY)
Total Assets
$23.97M
Total Liabilities
$49.87M
Total Investments
$0
TLSI Income (MRY)
Revenue
$29.43M
Net Income
-$30.05M
Operating Expense
$61.49M
TLSI Cash Flow (MRY)
CF Operations
-$40.84M
CF Investing
-$345.00K
CF Financing
$37.94M
TLSI Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $23,971,000 (-2.55%) | $24,598,000 (11.83%) | $21,995,000 (-41.87%) | $37,837,000 (-84.99%) |
Assets Current | $20,669,000 (-0.93%) | $20,862,000 (21.19%) | $17,214,000 (-51.00%) | $35,131,000 (1649.38%) |
Assets Non-Current | $3,302,000 (-11.62%) | $3,736,000 (-21.86%) | $4,781,000 (76.68%) | $2,706,000 (-98.92%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $802,000 (1.01%) | $794,000 (0%) |
Shareholders Equity | -$25,894,000 (4.33%) | -$27,065,000 (84.65%) | -$176,330,000 (-36.05%) | -$129,604,000 (-503.25%) |
Property Plant & Equipment Net | $2,879,000 (-11.96%) | $3,270,000 (-9.47%) | $3,612,000 (101.00%) | $1,797,000 (0%) |
Cash & Equivalents | $8,525,000 (-27.61%) | $11,777,000 (25.10%) | $9,414,000 (-68.93%) | $30,301,000 (2169.74%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $4,048,000 (59.06%) | $2,545,000 (73.01%) | $1,471,000 (13.85%) | $1,292,000 (0%) |
Trade & Non-Trade Receivables | $5,087,000 (43.13%) | $3,554,000 (128.26%) | $1,557,000 (14.74%) | $1,357,000 (0%) |
Trade & Non-Trade Payables | $2,274,000 (-32.94%) | $3,391,000 (-31.45%) | $4,947,000 (280.54%) | $1,300,000 (0%) |
Accumulated Retained Earnings (Deficit) | -$279,549,000 (-12.04%) | -$249,504,000 (-33.88%) | -$186,358,000 (-36.68%) | -$136,342,000 (-534.59%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $23,629,000 (1381.44%) | $1,595,000 (-18.75%) | $1,963,000 (0%) | $0 (0%) |
Debt Current | $216,000 (-38.46%) | $351,000 (-5.14%) | $370,000 (0%) | $0 |
Debt Non-Current | $23,413,000 (1782.07%) | $1,244,000 (-21.91%) | $1,593,000 (0%) | $0 |
Total Liabilities | $49,865,000 (-3.48%) | $51,663,000 (50.54%) | $34,319,000 (394.94%) | $6,934,000 (-70.49%) |
Liabilities Current | $10,228,000 (-30.36%) | $14,687,000 (-54.61%) | $32,357,000 (407.72%) | $6,373,000 |
Liabilities Non-Current | $39,637,000 (7.20%) | $36,976,000 (1784.61%) | $1,962,000 (249.73%) | $561,000 |
TLSI Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $29,431,000 (58.99%) | $18,511,000 (49.31%) | $12,398,000 (47.58%) | $8,401,000 (0%) |
Cost of Revenue | $4,103,000 (57.50%) | $2,605,000 (15.37%) | $2,258,000 (89.27%) | $1,193,000 (0%) |
Selling General & Administrative Expense | $43,805,000 (8.04%) | $40,546,000 (60.76%) | $25,221,000 (48.22%) | $17,016,000 (15583.96%) |
Research & Development Expense | $17,688,000 (-40.71%) | $29,835,000 (39.69%) | $21,358,000 (50.15%) | $14,224,000 (0%) |
Operating Expenses | $61,493,000 (-12.63%) | $70,381,000 (49.75%) | $46,999,000 (54.13%) | $30,494,000 (28006.88%) |
Interest Expense | $3,090,000 (19212.50%) | $16,000 (1500.00%) | $1,000 (-99.94%) | $1,761,000 (0%) |
Income Tax Expense | $6,000 (-33.33%) | $9,000 (0.00%) | $9,000 (200.00%) | $3,000 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$30,045,000 (49.39%) | -$59,363,000 (-25.80%) | -$47,187,000 (-63.59%) | -$28,845,000 (-3954.74%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$30,045,000 (49.39%) | -$59,363,000 (-25.80%) | -$47,187,000 (-63.59%) | -$28,845,000 (-3954.74%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$30,045,000 (49.39%) | -$59,363,000 (-25.80%) | -$47,187,000 (-63.59%) | -$28,845,000 (-3954.74%) |
Weighted Average Shares | $25,331,753 (169.61%) | $9,395,748 (2934.71%) | $309,609 (41.31%) | $219,100 (-97.37%) |
Weighted Average Shares Diluted | $25,331,753 (169.61%) | $9,395,748 (2934.71%) | $309,609 (41.31%) | $219,100 (-97.37%) |
Earning Before Interest & Taxes (EBIT) | -$26,949,000 (54.58%) | -$59,338,000 (-25.78%) | -$47,177,000 (-74.21%) | -$27,081,000 (-3706.78%) |
Gross Profit | $25,328,000 (59.24%) | $15,906,000 (56.86%) | $10,140,000 (40.68%) | $7,208,000 (0%) |
Operating Income | -$36,165,000 (33.61%) | -$54,475,000 (-47.79%) | -$36,859,000 (-58.29%) | -$23,286,000 (-21363.14%) |
TLSI Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$345,000 (78.27%) | -$1,588,000 (11.09%) | -$1,786,000 (20.90%) | -$2,258,000 (99.10%) |
Net Cash Flow from Financing | $37,936,000 (-30.56%) | $54,629,000 (305.80%) | $13,462,000 (-73.48%) | $50,768,000 (-79.85%) |
Net Cash Flow from Operations | -$40,843,000 (19.25%) | -$50,578,000 (-56.53%) | -$32,313,000 (-42.37%) | -$22,697,000 (-3249.62%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,252,000 (-232.03%) | $2,463,000 (111.93%) | -$20,637,000 (-179.95%) | $25,813,000 (1833.56%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | -$1,000,000 (0.00%) | -$1,000,000 (0.00%) | -$1,000,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$345,000 (41.33%) | -$588,000 (25.19%) | -$786,000 (37.52%) | -$1,258,000 (0%) |
Issuance (Repayment) of Debt Securities | $22,323,000 (25758.62%) | -$87,000 (33.59%) | -$131,000 (89.95%) | -$1,303,000 (-631.69%) |
Issuance (Purchase) of Equity Shares | $15,613,000 (9719.50%) | $159,000 (69.15%) | $94,000 (74.07%) | $54,000 (-99.98%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $5,441,000 (288.09%) | $1,402,000 (280.98%) | $368,000 (237.61%) | $109,000 (0%) |
Depreciation Amortization & Accretion | $1,008,000 (13.77%) | $886,000 (122.61%) | $398,000 (-14.22%) | $464,000 (0%) |
TLSI Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 86.10% (0.23%) | 85.90% (5.01%) | 81.80% (-4.66%) | 85.80% |
Profit Margin | -102.10% (68.16%) | -320.70% (15.74%) | -380.60% (-10.83%) | -343.40% |
EBITDA Margin | -88.10% (72.10%) | -315.80% (16.30%) | -377.30% (-19.10%) | -316.80% |
Return on Average Equity (ROAE) | 114.00% (92.57%) | 59.20% (-33.03%) | 88.40% (6.63%) | 82.90% |
Return on Average Assets (ROAA) | -118.10% (52.85%) | -250.50% (-926.64%) | -24.40% (-67.12%) | -14.60% |
Return on Sales (ROS) | -91.60% (71.43%) | -320.60% (15.74%) | -380.50% (-18.02%) | -322.40% |
Return on Invested Capital (ROIC) | -128.10% (-112.49%) | 1025.90% (4076.36%) | -25.80% (-79.17%) | -14.40% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -3.82 (-206.41%) | -1.25 (-1912.90%) | -0.06 (17.33%) | -0.07 (99.94%) |
Price to Sales Ratio (P/S) | 4.31 (0.54%) | 4.29 (1615.60%) | 0.25 (-3.10%) | 0.26 |
Price to Book Ratio (P/B) | -5.9 (28.19%) | -8.22 (-362.09%) | -1.78 (25.36%) | -2.38 (80.50%) |
Debt to Equity Ratio (D/E) | -1.93 (-0.89%) | -1.91 (-878.97%) | -0.2 (-261.11%) | -0.05 (95.06%) |
Earnings Per Share (EPS) | -1.31 (80.65%) | -6.77 (95.81%) | -161.55 (-22.71%) | -131.65 (-146177.78%) |
Sales Per Share (SPS) | 1.16 (-41.02%) | 1.97 (-95.08%) | 40.04 (4.44%) | 38.34 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.63 (70.14%) | -5.45 (94.91%) | -106.91 (2.22%) | -109.33 (-134880.25%) |
Book Value Per Share (BVPS) | -1.02 (64.53%) | -2.88 (99.49%) | -569.52 (3.72%) | -591.53 (-22880.92%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.95 (-63.87%) | 2.62 (-96.18%) | 68.45 (-59.51%) | 169.07 (459.91%) |
Enterprise Value Over EBIT (EV/EBIT) | -6 (-100.00%) | -3 (57.14%) | -7 (36.36%) | -11 (97.02%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -6.36 (-83.33%) | -3.47 (48.48%) | -6.73 (41.92%) | -11.59 (96.86%) |
Asset Turnover | 1.16 (48.14%) | 0.78 (1120.31%) | 0.06 (52.38%) | 0.04 |
Current Ratio | 2.02 (42.32%) | 1.42 (166.92%) | 0.53 (-90.35%) | 5.51 |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$41,188,000 (19.50%) | -$51,166,000 (-54.58%) | -$33,099,000 (-38.17%) | -$23,955,000 (-3435.28%) |
Enterprise Value (EV) | $164,932,616 (-18.63%) | $202,689,954 (-35.63%) | $314,873,902 (2.08%) | $308,472,195 (17.51%) |
Earnings Before Tax (EBT) | -$30,039,000 (49.39%) | -$59,354,000 (-25.81%) | -$47,178,000 (-63.57%) | -$28,842,000 (-3954.32%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$25,941,000 (55.62%) | -$58,452,000 (-24.95%) | -$46,779,000 (-75.75%) | -$26,617,000 (-3641.55%) |
Invested Capital | $28,847,000 (10744.65%) | -$271,000 (98.54%) | -$18,615,000 (-5144.72%) | $369,000 (-99.85%) |
Working Capital | $10,441,000 (69.09%) | $6,175,000 (140.78%) | -$15,143,000 (-152.66%) | $28,758,000 |
Tangible Asset Value | $23,971,000 (-2.55%) | $24,598,000 (16.07%) | $21,193,000 (-42.79%) | $37,043,000 (-85.30%) |
Market Capitalization | $152,770,616 (-31.30%) | $222,375,954 (-29.05%) | $313,437,500 (1.52%) | $308,750,000 (17.62%) |
Average Equity | -$26,350,000 (73.74%) | -$100,353,500 (-88.09%) | -$53,352,956 (-53.29%) | -$34,804,200 |
Average Assets | $25,442,000 (7.34%) | $23,701,250 (-87.76%) | $193,568,751 (-2.19%) | $197,900,366 |
Invested Capital Average | $21,041,000 (463.78%) | -$5,784,000 (-103.16%) | $182,875,440 (-2.74%) | $188,020,892 |
Shares | 30,493,137 (15.87%) | 26,316,681 (-15.79%) | 31,250,000 (0.00%) | 31,250,000 (25.00%) |
